Soon Ji Yoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Soon Ji Yoo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Tae Woong Seo
Department of Biology, Kyung Hee University, Seoul, Korea
7 shared publications Ji Sun Lee
Department of Nanopharmaceutical Life Sciences, Research Institute for Basic Sciences, Kyung Hee University, Seoul, 130-701, South Korea
5 shared publicationsYe Na Choi
Department of Biology Kyung Hee University Seoul South Korea
5 shared publications- Dar Heum Jeong
Department of Nanopharmaceutical Life Sciences, Research Institute for Basic Sciences, Kyung Hee University, Seoul, 130-701, South Korea
3 shared publications - Ji Woo Kang
Department of Biology Kyung Hee University, Seoul, 02447, Republic of Korea
2 shared publications Sun Kyung Lee
Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, Korea
2 shared publications
Latest Publications
- 18 June 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 776, 152218
Double-stranded RNA adenosine deaminases suppress ferroptosis through regulating SCD1
- 18 June 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 776, 152218
Double-stranded RNA adenosine deaminases suppress ferroptosis through regulating SCD1
- 14 December 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 743, 151189
cIAP2 supports the cell growth-promoting activity of FMR1 in gastric cancer via CARD-RING domains
- 14 December 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 743, 151189
cIAP2 supports the cell growth-promoting activity of FMR1 in gastric cancer via CARD-RING domains
- Open Access
- 13 February 2023
- Published by Wiley in FEBS Open Bio
- Vol. 13 (4) , 655-669
Nuclear endonuclease G controls cell proliferation in ovarian cancer
Ovarian cancer is characterized by a high degree of genetic heterogeneity. Platinum‐based chemotherapy and some gene‐targeted therapies have shown limited treatment efficacy due to toxicity and recurrence, and thus, it is essential to identify additional therapeutic targets based on an understanding of the pathological mechanism. Here, we report that endonuclease G, which exhibits altered expression in ovarian cancer, does not function as a cell death effector that digests chromosomal DNA in ovarian cancer. Endonuclease G is modulated by intracellular reactive oxygen species dynamics and plays a role in cell proliferation in ovarian cancer, suggesting that targeting endonuclease G alone or in combination with other antitumor agents may have the potential for development into a treatment for endonuclease G‐overexpressing cancers, including ovarian cancer.
- 13 February 2023
- Published by Wiley in FEBS Open Bio
- Vol. 13 (4) , 655-669
Open AccessNuclear endonuclease G controls cell proliferation in ovarian cancer
Ovarian cancer is characterized by a high degree of genetic heterogeneity. Platinum‐based chemotherapy and some gene‐targeted therapies have shown limited treatment efficacy due to toxicity and recurrence, and thus, it is essential to identify additional therapeutic targets based on an understanding of the pathological mechanism. Here, we report that endonuclease G, which exhibits altered expression in ovarian cancer, does not function as a cell death effector that digests chromosomal DNA in ovarian cancer. Endonuclease G is modulated by intracellular reactive oxygen species dynamics and plays a role in cell proliferation in ovarian cancer, suggesting that targeting endonuclease G alone or in combination with other antitumor agents may have the potential for development into a treatment for endonuclease G‐overexpressing cancers, including ovarian cancer.
- 1 September 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 530 (2) , 440-447
Stabilization of C-terminal binding protein 2 by cellular inhibitor of apoptosis protein 1 via BIR domains without E3 ligase activity
- 1 September 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 530 (2) , 440-447
Stabilization of C-terminal binding protein 2 by cellular inhibitor of apoptosis protein 1 via BIR domains without E3 ligase activity
- 1 November 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 506 (3) , 423-428
Ubiquitin-proteasome dependent regulation of Profilin2 (Pfn2) by a cellular inhibitor of apoptotic protein 1 (cIAP1)
- 1 November 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 506 (3) , 423-428
Ubiquitin-proteasome dependent regulation of Profilin2 (Pfn2) by a cellular inhibitor of apoptotic protein 1 (cIAP1)
- Open Access
- 29 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-13
A novel function of cIAP1 as a mediator of CHIP-driven eIF4E regulation
EIF4E is an initiator protein in cap-dependent translation. Its overexpression is linked to tumorigenesis in various human cancers, suggesting that the levels of eIF4E must be under tight control in normal cells. Although several eIF4E regulatory mechanisms have been demonstrated, the intracellular mechanisms controlling eIF4E protein levels remain poorly understood. Here, we report that eIF4E is efficiently regulated by dual mechanisms, both involving human inhibitor of apoptosis family protein cIAP1. cIAP1 itself ubiquitinates eIF4E as an E3 ligase, and interestingly, cIAP1 also functions as a mediator to present eIF4E to another E3 ligase, CHIP. This collaborative activity of cIAP1 and CHIP directs eIF4E toward degradation, controlling its levels and suppressing tumorigenesis. Our results provide the first evidence for a mediator function of cIAP1 and collaborative activity of cIAP1 and CHIP, suggesting that maintaining balanced levels of these E3 ligases might be beneficial for normal cell growth.
- 29 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-13
Open AccessA novel function of cIAP1 as a mediator of CHIP-driven eIF4E regulation
EIF4E is an initiator protein in cap-dependent translation. Its overexpression is linked to tumorigenesis in various human cancers, suggesting that the levels of eIF4E must be under tight control in normal cells. Although several eIF4E regulatory mechanisms have been demonstrated, the intracellular mechanisms controlling eIF4E protein levels remain poorly understood. Here, we report that eIF4E is efficiently regulated by dual mechanisms, both involving human inhibitor of apoptosis family protein cIAP1. cIAP1 itself ubiquitinates eIF4E as an E3 ligase, and interestingly, cIAP1 also functions as a mediator to present eIF4E to another E3 ligase, CHIP. This collaborative activity of cIAP1 and CHIP directs eIF4E toward degradation, controlling its levels and suppressing tumorigenesis. Our results provide the first evidence for a mediator function of cIAP1 and collaborative activity of cIAP1 and CHIP, suggesting that maintaining balanced levels of these E3 ligases might be beneficial for normal cell growth.
- 1 October 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 453 (1) , 192-197
Regulation of fragile X mental retardation 1 protein by C-terminus of Hsc70-interacting protein depends on its phosphorylation status
- 1 October 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 453 (1) , 192-197
Regulation of fragile X mental retardation 1 protein by C-terminus of Hsc70-interacting protein depends on its phosphorylation status
- 1 September 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 451 (4) , 644-649
Cellular Inhibitor of Apoptosis Protein 1 ubiquitinates endonuclease G but does not affect endonuclease G-mediated cell death
- 1 September 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 451 (4) , 644-649
Cellular Inhibitor of Apoptosis Protein 1 ubiquitinates endonuclease G but does not affect endonuclease G-mediated cell death
- 1 April 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 446 (4) , 1060-1066
C-terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration
- 1 April 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 446 (4) , 1060-1066
C-terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration
- Open Access
- 13 June 2013
- Published by Springer Nature in Cell Death & Disease
- Vol. 4 (6) , e666
CHIP has a protective role against oxidative stress-induced cell death through specific regulation of Endonuclease G
Oxidative stress is implicated in carcinogenesis, aging, and neurodegenerative diseases. The E3 ligase C terminus of Hsc-70 interacting protein (CHIP) has a protective role against various stresses by targeting damaged proteins for proteasomal degradation, and thus maintains protein quality control. However, the detailed mechanism by which CHIP protects cells from oxidative stress has not been demonstrated. Here, we show that depletion of CHIP led to elevated Endonuclease G (EndoG) levels and enhanced cell death upon oxidative stress. In contrast, CHIP overexpression reduced EndoG levels, and resulted in reduced or no oxidative stress-induced cell death in cancer cells and primary rat cortical neurons. Under normal conditions Hsp70 mediated the interaction between EndoG and CHIP, downregulating EndoG levels in a Hsp70/proteasome-dependent manner. However, under oxidative stress Hsp70 no longer interacted with EndoG, and the stabilized EndoG translocated to the nucleus and degraded chromosomal DNA. Our data suggest that regulation of the level of EndoG by CHIP in normal conditions may determine the sensitivity to cell death upon oxidative stress. Indeed, injection of H2O2 into the rat brain markedly increased cell death in aged mice compared with young mice, which correlated with elevated levels of EndoG and concurrent downregulation of CHIP in aged mice. Taken together, our findings demonstrate a novel protective mechanism of CHIP against oxidative stress through regulation of EndoG, and provide an opportunity to modulate oxidative stress-induced cell death in cancer and aging.
- 13 June 2013
- Published by Springer Nature in Cell Death & Disease
- Vol. 4 (6) , e666
Open AccessCHIP has a protective role against oxidative stress-induced cell death through specific regulation of Endonuclease G
Oxidative stress is implicated in carcinogenesis, aging, and neurodegenerative diseases. The E3 ligase C terminus of Hsc-70 interacting protein (CHIP) has a protective role against various stresses by targeting damaged proteins for proteasomal degradation, and thus maintains protein quality control. However, the detailed mechanism by which CHIP protects cells from oxidative stress has not been demonstrated. Here, we show that depletion of CHIP led to elevated Endonuclease G (EndoG) levels and enhanced cell death upon oxidative stress. In contrast, CHIP overexpression reduced EndoG levels, and resulted in reduced or no oxidative stress-induced cell death in cancer cells and primary rat cortical neurons. Under normal conditions Hsp70 mediated the interaction between EndoG and CHIP, downregulating EndoG levels in a Hsp70/proteasome-dependent manner. However, under oxidative stress Hsp70 no longer interacted with EndoG, and the stabilized EndoG translocated to the nucleus and degraded chromosomal DNA. Our data suggest that regulation of the level of EndoG by CHIP in normal conditions may determine the sensitivity to cell death upon oxidative stress. Indeed, injection of H2O2 into the rat brain markedly increased cell death in aged mice compared with young mice, which correlated with elevated levels of EndoG and concurrent downregulation of CHIP in aged mice. Taken together, our findings demonstrate a novel protective mechanism of CHIP against oxidative stress through regulation of EndoG, and provide an opportunity to modulate oxidative stress-induced cell death in cancer and aging.